Anti-inflammatory diets could lower dementia risk among older individuals with cardiometabolic disorders

FHS
August 15, 2024
10:51 am

Researchers investigated whether anti-inflammatory diets support cognitive functions among cardiometabolic disease (CMD) patients.

Asceneuron secures $100m for neurodegenerative treatments

Asceneuron’s lead compound, ASN51, is intended for Alzheimer’s disease treatment. Credit: fizkes/Shutterstock. Clinical-stage biotech company Asceneuron has announced an oversubscribed Series C financing round, securing

July 16, 2024

Opinion | No-Shows Have Got to Go!

Fred Pelzman of Weill Cornell Internal Medicine Associates and weekly blogger for MedPage Today, follows what’s going on in the world of primary care medicine

August 1, 2023

UCL researchers develop new gene therapy to cure severe childhood epilepsy

UCL researchers have developed a new gene therapy to cure a devastating form of childhood epilepsy, which a new study shows can significantly reduce seizures

December 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.